
Ritlecitinib is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents12 years and older.
Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.
from FDA,2023.06
When should Ritlecitinib NOT be used?Before starting treatment with Ritlecitinib, the following conditions must be ruled out: you are absolutely prohibited from using Ritlecitinib ···【more】
Article source:Lucius LaosRelease date:2026-05-18Recommended:34
Mechanism of Action and Use of RitlecitinibRitlecitinib is a hard capsule containing 50 mg of the active substance ritlecitinib per capsule. This medicine is used to treat severe a···【more】
Article source:Lucius LaosRelease date:2026-05-18Recommended:36
Uses of RitlecitinibThe core active ingredient of Ritlecitinib is ritlecitinib. It is used to treat severe alopecia areata in adults and adolescents aged 12 years and older. Alopec···【more】
Article source:Lucius LaosRelease date:2026-05-14Recommended:47
Suitable for treating severe alopecia areata in adults and adolescents aged 12 and above.【more】
Article source:Lucius LaosRelease date:2026-01-06Recommended:34

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643